Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Alexion | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Alexion

Soliris revenues up 17% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alexion
 
1Q Revenues: $701 million (+17%)

1Q Earnings: $92.2 million (+1%)

Comments: Soliris saw steady increase of new patients in the U.S., Europe and Japan with sales of $665 million, up 17%. Strensiq for Hypophosphatasia launched with $33 million sales in initial countries. U.S. launch for Kanuma (sebelipase alfa) for Lysosomal Acid Lipase (LAL) deficiency is under way.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters